Clinical Trial Update: Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis [Phase 2]

View source ↗

Summary

Phase 2 trial of ursodeoxycholic acid (UDCA) for hepatic sarcoidosis has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Sarcoidosis

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Ethan Weinberg | Conditions: Hepatic Sarcoidosis, Elevated Alkaline Phosphatase | Phase 2 | Status: TERMINATED | Results posted: 2023-06-07